Clinical Efficacy of Modified Dashmoolarishta in Cervicitis
Cervicitis is one of the serious health issue facing by women in today’s era. Due to cervical cancer 200 patients are dying per day according to W.H.O. If cervicitis remains untreated, it leading into malignancy. Prevention of repeated occurancy is crucial management. cervicitis is having long term complications. So, to minimize the complication, this is an attempt to find better solution, which may fulfill the motto of an ideal treatment that is to cure the disease and prohibit the occurrence of disease.
This is an open clinical randomized study, Total 30 perimenopausal and menopausal patients were selected in Trial and control group for the study.
After screening of 42 patients in both groups. Out of them, total 30 patients were completed the study. The trial drug Modified Dashamoolarishta was given in the dose of 20 ml BD for 30 days with equal quantity of water and in control group, Tab. Doxycycline was given in the dose of 100 mg for 5 days and follow up was conducted after 30 days and 90 days.
Comparing the assessment criteria before and after treatment, the study revealed the statistically significant decrease in cervical redness, pain, discharge in trial group. Significant anti-inflammatory action was observed in pap smear test.
In the present study, it has been proved that modified dashmoolarishta had good effect on cervicitis. No any adverse or side effects was found during and after the treatment.
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, will not be published elsewhere in the same form, in English or in any other language, without the written consent of the Publisher. The Editors reserve the right to edit or otherwise alter all contributions, but authors will receive proofs for approval before publication.
Copyrights for articles published in International Journal of Innovative Knowledge Concepts are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author.